- Previous Close
910.00 - Open
920.10 - Bid --
- Ask --
- Day's Range
900.00 - 920.15 - 52 Week Range
725.00 - 1,175.90 - Volume
80,367 - Avg. Volume
911,908 - Market Cap (intraday)
140.203B - Beta (5Y Monthly) --
- PE Ratio (TTM)
10,175.00 - EPS (TTM)
0.09 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Akums Drugs and Pharmaceuticals Limited manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally. It offers dosage forms, such as tablets, hard and soft gelatin capsules, liquid orals, sachets, vials, ampoules, form fill seals, topical preparations, eye drops, dry powder injections, rotacaps and gummies, and others. The company operates as pharmaceutical contract development and manufacturing company. It also sells branded pharmaceutical formulations. The company was incorporated in 2004 and is based in Delhi, India.
www.akums.in7,388
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: AKUMS.NS
View More
Performance Overview: AKUMS.NS
Trailing total returns as of 10/21/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AKUMS.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AKUMS.NS
View MoreValuation Measures
Market Cap
139.29B
Enterprise Value
142.07B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.56
Price/Book (mrq)
19.64
Enterprise Value/Revenue
3.53
Enterprise Value/EBITDA
108.77
Financial Highlights
Profitability and Income Statement
Profit Margin
5.78%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
42.31B
Net Income Avi to Common (ttm)
2.44B
Diluted EPS (ttm)
0.09
Balance Sheet and Cash Flow
Total Cash (mrq)
2.77B
Total Debt/Equity (mrq)
78.45%
Levered Free Cash Flow (ttm)
--
Company Insights: AKUMS.NS
AKUMS.NS does not have Company Insights